SWOG 1925 Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy in CLL/SLL

January 19, 2021
https://Clinicaltrials.gov/ct2/show/NCT04269902
Cancer - Leukemia, Cancer - Lymphoma
Principal Investigator: Ding Wang, MD
leukemia, lymphoma, CLL, SLL, BLOOD, CANCER, BLOOD CANCER
In Progress